Flagship Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Flagship Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.44K	Hold	59	–	–	﹤0.01%	339
2025 Q4	$1.71K	Hold	59	–	–	﹤0.01%	375
2025 Q3	$1.64K	Hold	59	–	–	﹤0.01%	394
2025 Q2	$1.44K	Hold	59	–	–	﹤0.01%	354
2025 Q1	$1.23K	Hold	59	–	–	﹤0.01%	361
2024 Q4	$1.39K	Buy	+59	New	+$1.45K	﹤0.01%	355

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Flagship Wealth Advisors's ARKG Position: Q1 2026 in Review

Flagship Wealth Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 59 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Flagship Wealth Advisors first reported a position in ARKG in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.71K in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Flagship Wealth Advisors held 59 shares of ARK Genomic Revolution ETF worth $1.44K as of Q1 2026.
Flagship Wealth Advisors left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Flagship Wealth Advisors's portfolio in Q1 2026, its #339 holding.
Flagship Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 6 quarters since.
Flagship Wealth Advisors's ARK Genomic Revolution ETF position peaked at $1.71K in Q4 2025.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Flagship Wealth Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.